Cargando…

Analysis of anti-Ro52 antibodies in sera of healthy subjects

Detalles Bibliográficos
Autores principales:	Zimmermann, C, Fabini, G, Höfler, E, Smolen, JS, Steiner, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273192/ http://dx.doi.org/10.1186/ar287

Ejemplares similares

Comparative analysis of anti-histone and anti-chromatin antibody specificity in lupus erythematosus cell-positive and -negative sera and their relation to disease activity
por: Schett, G, et al.
Publicado: (2001)

Autoantibodies to the mRNA destabilizing protein hnRNP-D/AUF1 in patients with systemic autoimmune diseases
por: Skriner, K, et al.
Publicado: (2001)

Zinc finger domain of Ro60kD autoantigen is essential for binding of Ro52kD and autoantibodies
por: Routsias, JG, et al.
Publicado: (2003)

Autoantibodies to the TNF-α translational regulators TIA-1 and TIAR occur frequently in sera of patients with SLE and scleroderma
por: Jimenez-Boj, E, et al.
Publicado: (2002)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003)

Anti-nuclear antibody (ANA) analysis should include specific analysis of antibodies to SS-A/Ro
por: Dahle, C, et al.
Publicado: (2002)

Linking anti-Ro antibodies to fibrosis in congenital heart block: translation to a clinical trial
por: Buyon, Jill P, et al.
Publicado: (2014)

Anti-Ro/SSA antibodies in systemic sclerosis (SSc): determination of the fine specificity, clinical and laboratory correlations
por: Antonioli, C, et al.
Publicado: (2002)

Characterization of the T cell response to hnRNP-A2 (RA33) in HLA-DR4 transgenic mice
por: Hoffmann, M, et al.
Publicado: (2004)

Role of anti-Ro autoantibodies in systemic lupus erythematosus patients with recurrent myositis
por: Umer, S, et al.
Publicado: (2012)

Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases
por: Robbins, Ailsa, et al.
Publicado: (2019)

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Detection of anti-B/B' UsnRNP antibodies in connective tissue disease sera by Western immunoblot
por: Ghirardello, A, et al.
Publicado: (2001)

T lymphocytes of patients with SLE lack Stat4
por: Aringer, M, et al.
Publicado: (2001)

Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus
por: Menéndez, Aurora, et al.
Publicado: (2013)

Sicca syndrome in the same family – the importance of anti-Ro60, anti-Ro52 and anti-La antibody profiling in Sjögren’s syndrome
por: Koszarny, Arkadiusz, et al.
Publicado: (2021)

Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis
por: Gkoutzourelas, Athanasios, et al.
Publicado: (2018)

Comparison of different methods for the detection of the fine specificity of anti-Ro/SSA response
por: Cavazzana, I, et al.
Publicado: (2001)

Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B
por: Infantino, M., et al.
Publicado: (2013)

Overexpression of TNF causes bilateral sacroiliitis
por: Redlich, K, et al.
Publicado: (2004)

Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
por: Redlich, K, et al.
Publicado: (2001)

Interphase fluorescence in situ hybridization analysis of fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis
por: Kiener, HP, et al.
Publicado: (2001)

Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma
por: Ferreira, João Pedro, et al.
Publicado: (2012)

Enhanced transendothelial in vitro migration of scleroderma lymphocytes
por: Stummvoll, GH, et al.
Publicado: (2001)

Impaired T-cell rsponse to subsequent TCR-stimulation after anti-CD3 induced proliferation
por: Köller, MD, et al.
Publicado: (2001)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2012)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints of TNF-alpha transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Osteoclasts are essential for TNF-mediated joint destruction
por: Redlich, KR, et al.
Publicado: (2002)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004)

Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
por: Kryštůfková, Olga, et al.
Publicado: (2014)

Clinical characteristics of idiopathic interstitial pneumonias with anti-Ro52/tripartite motif-containing 21 antibodies
por: Tahara, Masahiro, et al.
Publicado: (2022)

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
por: Sclafani, A., et al.
Publicado: (2019)

Leflunomide leads to inhibition of transendothelial migration
por: Grisar, J, et al.
Publicado: (2001)

Investigation of the reactivity patterns of antifilaggrin antibodies in sera and synovial fluids from patients with rheumatoid arthritis using citrullinated synthetic peptides
por: Brózik, M, et al.
Publicado: (2003)

Phenotypic and functional deficiencies of monocyte derived dendritic cells in systemic lupus erythematosus patients
por: Scheinecker, C, et al.
Publicado: (2004)

Experimental Gas Gangrene: The Protection Afforded by Various Anti-sera and Anti-sera Mixtures
Publicado: (1919)

Regional variation in anti-endotoxin core antibody levels in healthy and preoperative surgical populations
por: Rashid, M, et al.
Publicado: (2003)

Overexpression of the autoantigen hnRNP-A2 (RA33), the tumour suppressor p53 and activated MAP-Kinase p38 in inflamed synovial tissue
por: Hayer, S, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_c1d35ijq774c1fh91h4a8v92i3